MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with N

Nilotinib

Nilotinib 50mg capsules

No stability information

Stability notes for Nilotinib 50mg capsules

There are no stability notes for this medicine.

Supplier

Tasigna 50mg capsules (Novartis Pharmaceuticals UK Ltd)

Nilotinib 150mg capsules

No stability information

Stability notes for Nilotinib 150mg capsules

There are no stability notes for this medicine.

Suppliers (4) of Nilotinib 150mg capsules
Nilotinib 150mg capsules (Accord-UK Ltd)
Nilotinib 150mg capsules (Teva UK Ltd)
Nilotinib 150mg capsules (Zentiva Pharma UK Ltd)
Tasigna 150mg capsules (Novartis Pharmaceuticals UK Ltd)

Nilotinib 200mg capsules

No stability information

Stability notes for Nilotinib 200mg capsules

There are no stability notes for this medicine.

Suppliers (4) of Nilotinib 200mg capsules
Nilotinib 200mg capsules (Accord-UK Ltd)
Nilotinib 200mg capsules (Teva UK Ltd)
Nilotinib 200mg capsules (Zentiva Pharma UK Ltd)
Tasigna 200mg capsules (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.